11. Cardiovasc.disorders

advertisement

D’YOUVILLE COLLEGE

BIOLOGY 307/607 - PATHOPHYSIOLOGY

Lecture 11 - CARDIOVASCULAR DISORDERS

1. Cardiac Anatomy & Physiology:

• anatomy: located in mediastinum (fig. 10 - 1 & ppt. 1), protected by sternum

- pericardium: heart is enclosed in pericardial cavity, bounded by parietal

pericardium and visceral pericardium (= epicardium) (figs. 10 -2, 10 - 3 & ppts. 2 & 3); pericardium is anchored to diaphragm

- myocardium: cardiac muscle constitutes middle layer; fibrous skeleton

(annuli fibrosi) encloses valves (fig. 10 - 4 & ppt. 4); provides anchorage for muscle

(fig. 10 - 5 & ppt. 5)

- endocardium: thin internal lining of epithelium, continuous with endothelium of blood vessels (fig. 10 - 3 & ppt. 3)

- chambers: two atria (reception chambers) and two ventricles (pumping chambers); left side pumps to systemic circuit & right side pumps to pulmonary circuit) (fig. 10 - 6 & ppts. 6 & 7)

- valves: atrioventricular valves (tricuspid - right; mitral - left) separate atria from ventricles and semilunar valves (pulmonary - right; aortic - left) separate ventricles from arteries (figs. 10 - 4, 10 - 8 & ppt. 4)

- valves facilitate one-way flow (fig. 10 - 7) through the heart -- from atrium to ventricle and from ventricle to artery; atrioventricular valve function is aided by attachment to papillary muscles via chordae tendineae (fig. 10 - 9)

• cardiac cycle (ppt. 8): = one heartbeat; two main periods -- systole

(contraction) & diastole (relaxation) -- usually in reference to ventricular activity

- diastole accomplishes filling of both atrium and ventricle; end-diastolic

volume = amount of blood in heart at end of diastole

- systole accomplishes pumping of blood into the arteries; end-systolic

volume = amount of blood in heart at end of systole

Bio 307/607 lec 11 - p. 2 -

- stroke volume = amount pumped/cycle (EDV - ESV = SV); may be elevated by increased venous return (preload), or by factors that stimulate contractility (positive inotropic effect), e.g. sympathetic NS, epinephrine, digitalis; SV may be depressed by factors opposing ventricular emptying (afterload), or factors that decrease contractility (negative inotropic effect), e.g. hypoxia, toxins

- heart rate: accelerated (positive chronotropic effect) by various stimuli, e.g. increased sympathetic signal, epinephrine; slowed (negative chronotropic effect) by increased parasympathetic signal (fig. 10 - 12 & ppt. 9)

- cardiac output is the volume of blood pumped by left ventricle per minute, and is governed by heart rate (beats per minute) and SV; CO = SV x HR

• electrical activity of heart (fig. 10 - 10 & ppt. 10): SA node = pacemaker in right atrial myocardium governs the heart rate -- sinus rhythm

- atrial myocardium conducts the signal throughout both atria; AV node is needed to pass the signal across the annuli fibrosi to the ventricles; this involves a

delay of signal (~.12 - .2 sec.); thus, atria contract before ventricles contract

- AV bundle & Purkinje fibers relay signal from AV node throughout ventricular myocardium

- irritated regions of myocardium (ectopic foci) may override pacemaker causing departure from sinus rhythm & altered heart function

• ECG or EKG (electrocardiograph): recording of heart's electrical activity features P wave (depolarization of atria), QRS complex (ventricular depolarization),

& T wave (ventricular repolarization) (fig. 10 - 11 & ppt. 11)

- PR interval = time from beginning of P wave to beginning of R spike = AV node delay; extended PR intervals are known as 'heart blocks' and signify impairment of

AV node, AV bundle or Purkinje system

- ST segment = time from end of QRS complex to beginning of T wave;

depressed or elevated ST segments indicate myocardial ischemia or infarction

- many other findings from EKG are valuable in diagnosing various heart problems (see text pp. 250 - 251 & ppt. 12)

Bio 307/607 lec 11 - p. 3 -

• coronary circulation (fig. 10 - 14 & ppt. 13): left coronary a. produces anterior

interventricular (left anterior descending) branch and circumflex branch branch

- right coronary a. supplies a posterior interventricular (posterior descending)

2. Heart Failure: inability to maintain adequate cardiac output

• acute heart failure: rapid onset (few seconds to a few days), lethal to about

1/3 of sufferers

• chronic heart failure: gradual accumulation of impairments

(mostly due to ischemic heart disease - see below); sufferers are vulnerable to sudden acute

failure due to therapeutic failure or excessive demand, e.g. snow shoveling

3. Ischemic Heart Disease (IHD):

• coronary artery disease (CAD): consequence of atherosclerosis, usually in aorta and its branches, including coronaries; also called atherosclerotic heart disease

(ASHD)

- plaques or emboli may obstruct coronary circulation causing ischemia,

angina pectoris (fig. 10 - 20 & ppt.14), infarction, and weakening of the heart perhaps to point of failure

- ischemia: impaired blood flow

- chronic ischemia often develops slowly enough to permit adaptive changes, e.g., development of collateral circulation

- acute ischemia is sudden and often leads to acute myocardial infarction

(MI) (fig. 10 - 19)

- ischemia most often develops in left coronary and its branches, frequently involving multiple plaques (may necessitate multiple bypasses)

• acute myocardial infarction: plaque rupture & bleeding into lesion produces thrombosis and severe ischemia resulting in necrosis of downstream myocardium

- symptoms vary from almost no pain to intense angina accompanied by dyspnea, diaphoresis, and extreme anxiety

Bio 307/607 lec 11 - p. 4 -

- signs - derived from ECG and from monitoring of levels of various blood

components: creatine kinase, lactic dehydrogenase (enzymes released from damaged muscle), & troponin (contractile protein released from damaged heart muscle)

- treatments involve coronary bypass surgery (using great saphenous veins, sections of mammary arteries, internal thoracic arteries, or artificial Teflon vessels)

- angioplasty (distending narrowed vessel with balloon catheter, followed by insertion of a stent)

- administration of tissue plasminogen activator (t-PA), a 'clot buster' may be used but its effects may be delayed, compared to benefits of angioplasty

- sequelae of acute MI may include arrhythmias (including dangerous ventricular fibrillation), thrombosis, cardiogenic shock (due to heart failure), ventricular

aneurysm (fig. 10 - 21 & ppt. 15) and danger of rupture (causes abrupt hemopericardium that leads to rapid heart failure) (fig. 10 - 22 & ppt. 16)

4. Congestive Heart Failure (= chronic heart failure - CHF):

• left-sided failure: usually the first to occur (compromised cardiac output, e.g., fig. 10 - 24 & ppt. 17), followed by right-sided failure

- characterized by lung conditions, e.g., edema, congestion (poor venous drainage) or by failing dependent organs, e.g. kidney failure, cerebral ischemia

• right-sided failure is characterized by congestion of liver (hepatomegaly), spleen

(splenomegaly), and kidney (impaired clearing of fluids, nitrogenous waste)

- cor pulmonale produces right-sided failure independently of left-sided failure,

due to pulmonary hypertension from various lung conditions (emphysema, embolisms, pulmonary fibrosis: see table 10 - 5)

• etiology: may stem from weakened myocardium, pumping restrictions, or increased afterload

- i) myocardial weakness most often due to ischemia from coronary

atherosclerosis (fig. 9 - 20 & ppt. 18)) or coronary thrombosis

- other contributing conditions: myocarditis (see below) or cardiomyopathy

(fig. 10 - 37 & ppts. 19 & 20), which may produce dilated (thin, distended myocardium), hypertrophic (thickened myocardium that may restrict ventricular lumen), restrictive (stiffening of myocardium) conditions, or a combination of these

Bio 307/607 lec 11 - p. 5 -

- ii) restrictions to pumping (table 10 - 4) arise from valvular disorders, from obstructions (e.g., tumor, - fig. 10 - 25 & ppt. 21)

- congenital heart defects (figs. 10 - 38, 10 - 39, 10 - 41, table 10 -8 & ppts.22 to 24) include ventricular septal defects, tetralogy of Fallot, aortic coarctation &

patent ductus arteriosus (PDA)

- disturbances of electrical rhythm (dysrhythmias, e.g., heart blocks, fibrillation), and pericarditis (see below) with associated tamponade, are other factors that may restrict pumping (fig. 10 - 22 & ppt. 16)

- iii) increased afterload includes any conditions increasing heart's workload, most often systemic conditions provoking left-sided failure as a prelude to both-sided failure; systemic hypertension is most likely cause

- summary of etiologic factors for CHF (fig. 10 - 26 & ppt. 25)

- pathogenesis of CHF (figs. 10 - 27, 10 - 30 & ppt. 26): pulmonary

hypertension and associated consequences follow left-sided failure, as well as weakness & fatigue (due to reduced cardiac output); cardiomegaly (fig. 10 - 31 & ppt.

27) is a compensatory response of both sides, and hepatomegaly and splenomegaly follow right-sided failure

- compensations in CHF (fig. 10 - 32 & ppt. 28): cardiomegaly, renal adjustments (renin-angiotensin system), & nervous system adjustments (sympathetic outflow causes positive chronotropic and positive inotropic effects, as well as peripheral vasoconstriction)

5. Inflammatory Conditions:

• pericarditis: pericardial inflammation characterized by fluid accumulation in pericardial cavity (pericardial effusion); accumulated exudate = hydropericardium; accumulated blood = hemopericardium; such conditions impair ventricular filling due to external pressure on atria (cardiac tamponade) (fig. 10 - 22 & ppt. 29)

- acute pericarditis: effusions ranging from serous (watery) to fibrinous

(coagulative); rheumatic heart disease, myocardial infarction, and viral infections

(fig. 10 - 15) are causes; extensive adhesions severely compromise cardiac output

- chronic pericarditis: prolonged inflammation may cause 'hardening of the pericardium' (fibrosis & calcification)

- commonly associated with tuberculosis pericarditis

Bio 307/607 lec 11 - p. 6 -

• myocarditis: ranges from mild condition to one that involves serious weakening of myocardium; viral infection is commonest cause

• endocarditis: infective endocarditis (bacterial, fungal) exhibits typical lesion called a vegetation (fig. 10 - 16)

- vegetation is a thrombus, containing infective agents (which may be inaccessible to immune defenses)

- vegetations are most often associated with valves & may compromise

valve function

6. Valvular Disease (table 10 - 1):

• stenosis: failure to open effectively, often causing heart murmur

- commonly associated with rheumatic heart disease, infective endocarditis, congenital malformation, or calcification of cusps

- aortic stenosis compromises left ventricular output, causes left ventricular hypertrophy, & may lead to left-sided failure

• insufficiency: failure to close properly, results in regurgitation; often uneventful for many years & may be undiagnosed

7. Rheumatic Heart Disease (RHD) (fig. 10 - 18 & ppt. 30):

• rheumatic fever: more generalized inflammatory condition that includes

RHD, but also numerous other tissues (joints, skin, vessels, serosa, & lungs)

- usually post-streptococcal in origin resulting in valve disorders (most common) and may lead to congestive heart failure; cross-reacting antibodies cause lesions in uninfected tissues including myocardium

- most effective treatment is aimed at minimizing streptococcal infection via antibiotics, such as penicillin

8. Treatment Strategies (fig. 10 - 35 & ppt. 31):

- minimize thrombosis - antiplatelet drugs, blood thinners

- treatment of heart rate - positive or negative chronotropes

- treatment of contractility - positive or negative inotropes

- lower blood volume - diuretics

Bio 307/607 lec 11 - p. 7 -

- alleviate arrhythmias - antiarrhythmics

- reduce vascular resistance - vasodilators

Download